Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Nov;30 Suppl 8(Suppl 8):viii1-viii2.
doi: 10.1093/annonc/mdz409. Epub 2019 Dec 24.

Foreword

D M Hyman  1 , M Ladanyi  2
Affiliations
Editorial

Foreword

D M Hyman et al. Ann Oncol. 2019 Nov.
No abstract available

PubMed Disclaimer

References

    1. Barbacid M. On the right TRK: from oncogene discovery to cancer therapeutics. Ann Oncol 2019; 30 suppl. 8: viii3–viii4. - PMC - PubMed
    1. Amatu A, Sartore-Bianchi A, Bencardino K. et al. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol 2019; 30 suppl. 8: viii5–viii15. - PMC - PubMed
    1. Solomon JP, Benayed R, Hechtman JF, Ladanyi M.. Identifying patients with NTRK fusion cancer. Ann Oncol 2019; 30 suppl. 8: viii16–viii22. - PubMed
    1. Drilon A. TRK inhibitors in TRK fusion-positive cancers. Ann Oncol 2019; 30 suppl. 8: viii23–viii30. - PubMed
    1. Bielack SS, Cox MC, Nathrath M. et al. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. Ann Oncol 2019; 30 suppl. 8: viii31–viii35. - PubMed

Publication types

MeSH terms